» Articles » PMID: 35169970

Mesoporous Silica Carrier-Based Composites for Taste-Masking of Bitter Drug: Fabrication and Palatability Evaluation

Overview
Publisher Springer
Specialty Pharmacology
Date 2022 Feb 16
PMID 35169970
Authors
Affiliations
Soon will be listed here.
Abstract

Palatability is one of the most critical characteristics of oral preparations. Therefore, the exploration of new techniques to mask the aversive taste of drugs is in continuous demand. In this study, we fabricated and characterized composites based on mesoporous silica (MPS) that consisted of MPS, a bitter drug, and release regulators. We conducted a palatability evaluation to assess the taste-masking efficacy of the composites. The composites were prepared using the dry impregnation method combined with hot-melt extrusion. Morphology and components distribution in composites were characterized by scanning electron microscopy, confocal laser scanning microscopy, X-ray photoelectron spectroscopy, powder flow properties evaluation, and nitrogen-sorption measurement. The results demonstrated that drugs mainly existed in the inner pore of composites, and release regulators existed in the inner pore and covered the composites' surface. Interactions among the composite components were studied using powder X-ray diffraction, differential scanning calorimetry, and Fourier transform infrared spectroscopy. The drug loaded into the composites was amorphous, and an intermolecular interaction occurred between the drug and the MPS. Taste-masked composites significantly reduced drug release levels under mouth conditions; thus, they prevented the interaction of the dissolved drug with taste receptors and improved palatability. An electronic tongue evaluation and a human taste panel assessment confirmed the better palatability of taste-masked composites. Moreover, the desired drug release behavior can be adjusted by choosing an appropriate release regulator, with stronger hydrophobicity of release regulators resulting in slower drug release. This work has provided new insights into taste-masking strategies for drugs with unpleasant tastes.

Citing Articles

Evaluation of the bioavailability of a Tamiflu taste-masking pediatric formulation using a juvenile pig model and LC-MS/MS.

Wang J, Gu J, Faustino P, Siddiqui A, Zhao Y, Giacoia G Bioanalysis. 2024; 16(13):681-691.

PMID: 39254502 PMC: 11389739. DOI: 10.1080/17576180.2024.2352256.


Critical View on the Qualification of Electronic Tongues Regarding Their Performance in the Development of Peroral Drug Formulations with Bitter Ingredients.

Steiner D, Meyer A, Immohr L, Pein-Hackelbusch M Pharmaceutics. 2024; 16(5).

PMID: 38794320 PMC: 11125162. DOI: 10.3390/pharmaceutics16050658.

References
1.
Ternik R, Liu F, Bartlett J, Khong Y, Tan D, Dixit T . Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop. Int J Pharm. 2017; 536(2):570-581. DOI: 10.1016/j.ijpharm.2017.08.088. View

2.
Li C, Zhou K, Chen D, Xu W, Tao Y, Pan Y . Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin. Int J Nanomedicine. 2019; 14:1619-1631. PMC: 6402439. DOI: 10.2147/IJN.S183479. View

3.
Lopez F, Ernest T, Orlu M, Tuleu C . The effect of administration media on palatability and ease of swallowing of multiparticulate formulations. Int J Pharm. 2018; 551(1-2):67-75. DOI: 10.1016/j.ijpharm.2018.08.021. View

4.
Li S, Zhang Y, Khan A, He S, Wang Y, Xu J . Quantitative prediction of the bitterness of atomoxetine hydrochloride and taste-masked using hydroxypropyl-β-cyclodextrin: A biosensor evaluation and interaction study. Asian J Pharm Sci. 2020; 15(4):492-505. PMC: 7486553. DOI: 10.1016/j.ajps.2019.11.001. View

5.
Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R . Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014; 73:14-33. DOI: 10.1016/j.addr.2014.02.012. View